Among children with proven monogenic etiology of their short stature, only those with SHOX deficiency and Noonan syndrome are known to benefit from GH treatment, and the genetic diagnosis automatically indicates them for therapy (36, 37, 38). This evidence concerns the gene GH1 and Noonan syndrome.